Internal Server Error

About Practica Capital

Practica Capital is a venture capital firm founded in 2011. It is primarily based out of Vilnius, Lithuania. As of Aug 2025, Practica Capital is an active investor, having invested in 71 companies, with 3 new investments in the last 12 months. It primarily invests in Seed round in Lithuania based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Consumer. Most recently it participated in the $***** Seed round of CREEM Overall, Practica Capital portfolio has seen 1 IPO and 7 acquisitions including key companies like Oxipit, Trafi and Eddy Travels. A lot of funds co-invest with Practica Capital, with names like Mantas Mikuckas sharing a substantial percentage of its portfolio. Practica Capital has team of 17 people including 6 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

Practica Capital's List of Top Investments

Practica Capital has a portfolio of 71 companies. Their most notable investments are in CGTrader and HEI Schools.Their portfolio spans across Lithuania, United Kingdom, United States and 7 more locations. They have invested in Enterprise Applications, High Tech, Consumer and 28 other sectors, across stages such as Seed, Series A  and 2 more. Here is the list of top investments by Practica Capital:
Cross-border remittance solution for consumers and businesses. It allows consumers and businesses to transfer money and funds across borders. Users can transfer funds using cash deposits, bank transfers, and ATMs. Features APIs to manage transactions, access current pricing, and market trends and insights.

Key facts about TransferGo

  • Founded Year: 2012
  • Location: London (United Kingdom)
  • Annual Revenue: £32.5M as on Dec 31, 2021
  • Valuation: $*****
  • Stage: Series C
  • Total Funding till date: $110M
  • Employee Count: 369 as on Mar 31, 2026
  • Investors: Black River Ventures, VEF and 45 Others
  • Latest Funding Round: Series C, Apr 22, 2025, $*****
  • Highlight: Editors' Pick
Artificial intelligence-based medical image analysis for doctors. Solutions offered include ChestGlass, ChestEye, and QEye. ChestGlass is a solution that offers radiographs for comparison, to analyze anomalies. ChestEye is a computer-aided diagnosis (CAD) solution that analyses chest X-ray radiographs and provides information about enlarged heart, edema, pleural effusion, pulmonary emphysema, subcutaneous emphysema, and more.

Key facts about Oxipit

Trafi provides MaaS solutions to transit agencies & offers a consumer transit app. The custom-branded consumer-facing mobile application enables passengers to plan & book multi-modal transit tickets by combining various mobility options like taxis, rentals, or public transit. Offers a back-end management platform to operators covering aspects such as operations management, route planning, passenger management, and payments management.

Key facts about Trafi

  • Founded Year: 2013
  • Location: Vilnius (Lithuania)
  • Stage: Acquired
  • Total Funding till date: $15M
  • Employee Count: 2 as on Dec 31, 2024
  • Investors: EBRD, Octopus Investments and 6 Others
  • Latest Funding Round: Series B, Jul 2020, $*****
  • Highlight: Acquired
Eneba is an online retailer of digital games. The product catalog includes action-adventure games, animal & army games, Blizzard games, call of duty series, and more. The company offers games of multiple genres, types, operating systems, platforms, and more.

Key facts about Eneba

Atrandi Biosciences, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries.

Key facts about Atrandi Biosciences

Practica Capital's Investments by Stage

Practica Capital has made 55 investments in Seed stage with an average round size of $1.66M, 8 investments in Series A stage with an average round size of $7.2M, 1 investment in PE stage and 1 investment in Unattributed stage.
Here are Practica Capital's investments by stage:
Stage of entry
No. of Investments
Seed
55
Series A
8
PE
1
Unattributed
1
Breakdown of Practica Capital's investments by stage of entrySeed (55)Series A (8)
Note: We have considered here, only first round of investments

Practica Capital's Investments by Sector

Practica Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Consumer, High Tech, HealthTech and Retail. Notably, it has invested in 58 Tech companies, 41 Enterprise (B2B) companies, 33 Software companies and at least 32 companies focusing on Consumer (B2C).
Here are Practica Capital's investments by sector:
Sector
No. of Investments
Enterprise Applications
26
Consumer
19
High Tech
12
HealthTech
8
Retail
8
Others
76
Breakdown of Practica Capital's investments by sectorsEnterprise Applic... (26)Consumer (19)
Note: We have considered here, only first round of investments

Practica Capital's Investments by Geography

Practica Capital has made most investments in Lithuania (47), followed by United Kingdom where it has made 7 investments.
Here are Practica Capital's investments by geography:
Country
No. of Investments
Lithuania
47
United Kingdom
7
United States
4
Latvia
3
Estonia
1
Others
5
Breakdown of Practica Capital's investments by countriesLithuania (47)United Kingdom (7)
Note: We have considered here, only first round of investments

Practica Capital's recent investments

Practica Capital has not made any investment in 2026 so far.
Here are the most recent investments by Practica Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Aug 25, 2025
United States
Seed
2952
  [+2]
Aug 01, 2025
Latvia
Seed
8470
Jun 10, 2025
Lithuania
Seed
2473
Feb 19, 2025
Lithuania
Series A
7283
Nov 12, 2024
United Kingdom
Seed
9114
  [+1]

IPOs and Publicly Listed companies in Practica Capital's Portfolio

1 of Practica Capital's portfolio company became public -  JetCat Games.
Here are Practica Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
-
Aug 12, 2015
Seed
9103

Acquired companies in Practica Capital's Portfolio

7 companies from Practica Capital's portfolio have been acquired. The most recent acquisition was Oxipit in Mar 2026 by Sectra for $*****.
Here are Practica Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 05, 2026
Jul 16, 2019
Seed
7255
Apr 14, 2025
Oct 14, 2013
Seed
7916
Mar 27, 2024
2015
Series A
8366
Sep 08, 2022
Dec 23, 2019
Seed
9059
May 02, 2017
Mar 05, 2014
Seed
5590

Team profile of Practica Capital

Practica Capital has a team of 17 members including 6 Partners, 1 Venture Partner and 2 Principals located in Lithuania. Practica Capital's team does not sit on the board of any company as of now.
Here is a list of top team members in Practica Capital:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Vilnius
-
Partner
Vilnius
-
-
Partner
Vilnius
-
Partner
Lithuania
-
Partner
Lithuania
-
Partner
-
-
Venture Partner
Lithuania
-
-
Principal
-
-
Principal
Lithuania
-

Co-investors of Practica Capital

Over the past 14 years, 162 investors have co-invested in Practica Capital's portfolio companies. This includes funds and angels.

  • Invested before Practica CapitalEuropa, Imprimatur Capital Fund Management and 30 others have invested in rounds before Practica Capital. There are 2 companies where Europa has invested before Practica Capital and 2 companies where Imprimatur Capital Fund Management has invested before Practica Capital.
  • Top Co-investors of Practica Capital52 investors entered a company along with Practica Capital. These include investors like Mantas Mikuckas (5 companies).
  • Invested after Practica CapitalA total of 78 investors have invested in Practica Capital's portfolio after their investments. Top Investors include Taiwania Capital (2 companies), Trind VC (2 companies) and CoInvest Capital (2 companies).

Recent News related to Practica Capital

View all news related to Practica Capital

FAQs about Practica Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford